Select Page ::

India Flooring Adhesive Industry by Type, Application, Technology, End-use, Region and Company – Forecast to 2025 – GlobeNewswire

Posted on June 26, 2020 by Danzig

Dublin, June 26, 2020 (GLOBE NEWSWIRE) -- The "India Flooring Adhesive Market by Type (Epoxy Adhesives, Polyurethane Adhesives, Acrylic Adhesives, Vinyl Adhesives and Others), by Application (Tile & Stone, Carpet, Wood, Laminate and Others), by Technology, by End-use, by Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Indian Flooring Adhesives Market is anticipated to grow at a robust rate owing to the expansion in the building & construction sector which is driving utilization of flooring adhesives such as vinyl adhesives in wood and ply laminates in the country.

The commercial applications in the hospitality industry along with residential applications in flats & apartments due to the increasing demand for laminate, linoleum or wood flooring is driving the Indian Flooring Adhesives Market through 2025. Moreover, the affordability offered by flooring adhesives is expected to hasten their consumption in budget housings, consequently driving the Indian Flooring Adhesives Market.

Further, the increasing use of decorative and aesthetically pleasing flooring is also supporting the growth of the flooring adhesives market in India. With rise in disposable income, people are willing to spend on attractive flooring options. There are different types of adhesives available in the market and the selection is largely dependent on the flooring type as well as flooring application.

The Indian Flooring Adhesives Market is segmented based on type, application, technology, end-use and region. Based on type, the market is segmented into epoxy adhesives, polyurethane adhesives, acrylic adhesives, vinyl adhesives and others. The epoxy adhesive segment is undergoing the fastest growth and is expected to lead the market in terms of revenue share by 2025 owing to their preference over other adhesives.

Based on end-use, the Indian Flooring Adhesives Market is segmented into the residential, commercial and industrial. The residential segment is expected to dominate the market in the coming years owing to the rise in residential construction activities in the country to provide housing for the growing population.

Some of the leading players operating in Indian Flooring Adhesives Market are Pidilite Industries Ltd, Fosroc India, Huntsman Corporation, MYK LATICRETE INDIA PVT, Saint-Gobain Weber, Bostik, H.B. Fuller Company, SIKA INDIA, ADREX Group and Henkel AG & Co. KGaA, among others. Key manufacturing companies are launching new range of products to provide better adhesion. They are also working on brand promotion and product awareness to increase their market share.

Years considered for this report:

Objective of the Study

Key Topics Covered

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on India Flooring Adhesive Market

4. Executive Summary

5. Voice of Customer

6. Demand Supply Analysis6.1. Production6.2. Import6.3. Export6.4. Gap

7. India Flooring Adhesive Market Outlook7.1. Market Size & Forecast7.1.1. By Value & Volume7.2. Market Share & Forecast7.2.1. By Type (Epoxy Adhesives, Polyurethane Adhesives, Acrylic Adhesives, Vinyl Adhesives and Others)7.2.2. By Application (Tile & Stone, Carpet, Wood, Laminate and Others)7.2.3. By Technology (Water-based Adhesives, Solvent-based Adhesives and Hot-melt based Adhesives)7.2.4. By End-use (Residential, Commercial and Industrial)7.2.5. By Region7.2.6. By Company (2019)7.3. Market Attractiveness Index

8. India Epoxy Adhesives Market Outlook8.1. Market Size & Forecast8.1.1. By Value & Volume8.2. Market Share & Forecast8.2.1. By Application8.2.2. By End-use8.2.3. By State (Top 10 States)8.2.4. Company Share8.3. Pricing Analysis

9. India Polyurethane Adhesives Market Outlook9.1. Market Size & Forecast9.1.1. By Value & Volume9.2. Market Share & Forecast9.2.1. By Application9.2.2. By End-use9.2.3. By State (Top 10 States)9.2.4. Company Share9.3. Pricing Analysis

10. India Acrylic Adhesives Market Outlook10.1. Market Size & Forecast10.1.1. By Value & Volume10.2. Market Share & Forecast10.2.1. By Application10.2.2. By End-use10.2.3. By State (Top 10 States)10.2.4. Company Share10.3. Pricing Analysis

11. India Vinyl Adhesives Market Outlook11.1. Market Size & Forecast11.1.1. By Value & Volume11.2. Market Share & Forecast11.2.1. By Application11.2.2. By End-use11.2.3. By State (Top 10 States)11.2.4. Company Share11.3. Pricing Analysis

12. Market Dynamics12.1. Drivers12.2. Challenges

13. Market Trends & Development

14. Pricing Analysis

15. Raw Material Analysis (Sourcing-Domestic & International)

16. Cost Structure (Raw Material Cost, Selling & Distribution Cost, Employee Cost)

17. Policy & Regulatory Landscape

18. India Economic Profile

19. Competitive Landscape19.1. Pidilite Industries Ltd.19.2. Fosroc India19.3. Huntsman Corporation.19.4. MYK Laticrete India Pvt.19.5. Saint-Gobain Weber19.6. Bostik19.7. H.B. Fuller Company19.8. SIKA INDIA19.9. ADREX Group19.10. Henkel AG & Co. KGaA

20. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/c9rgcm

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

India Flooring Adhesive Industry by Type, Application, Technology, End-use, Region and Company - Forecast to 2025 - GlobeNewswire

The Voice turns to technology to keep Boy George and Kelly Rowland on board – Sydney Morning Herald

Posted on June 26, 2020 by Danzig

I mean, obviously theres no substitute for being with people and for being in that atmosphere, which is electrifying,

"But I have to say Im really surprised, and impressed, by how theyve pulled it together.

Boy George and Rowland will appear to be able to interact normally with the artists, and Aussie coaches Delta Goodrem and Guy Sebastian, thanks to a carefully redesigned set.

We look like were there but neither of us has got any legs, Boy George joked.

My legs are quite short anyway, so Im good with it.

This season he has two Western Australians on his team: 37-year-old Roxane Lebrasse, from Westminster, and 18-year-old Sebastian Coe, from Mount Pleasant.

Both are established singers but Boy George said experience wasn't always an advantage in the competition.

There isnt a sort of rule that says if you have years of experience youre going to come on the show and youre going to nail your blind, or youre going to do the next performance, because the show is probably throwing new situations at you," he said.

For me, everything matters: how you win a thing, how you lose it, how you hold your face. There are so many things we look at, as coaches.

Speaking as last years winning The Voice coach and someone who continues to have singing lessons and acting classes, he added: Its trusting yourself, its connecting with the viewers.

"Its all stuff like that that I pick up on because its stuff Ive done.

"All you really want to do as a coach is build someones confidence.

He says he's very comfortable with his team this year and isnt coveting any of the other coaches artists.

I have to say, this season, no.

"I mean theres loads of other people I think are great and I dont think theres any obvious winner this year I have no idea who is going to win.

While The Voice has already seen coaches accusing each other of cheating in their quest to produce the winning artist, Boy George said the bickering wasn't personal and five years on, he was still enjoying it.

You know Ive lived an interesting life and Ive got a lot of wisdom to impart and if people think thats value, then thats great.

The Culture Club frontman hasnt wasted any time in lockdown in the UK.

Instead hes been working on a new version of the bands 1983 smash hit Karma Chameleon, in virtual collaboration with a 16-year-old girl in France.

Obviously, through The Voice, people approach you and you get a lot of emails from people so I met a young girl last year, whos got a beautiful voice, and she had done this version of Karma that was so different to the original and then Ive redone it," he said.

"And, honestly, its really beautiful if a bit weird."

The Voice airs on Nine, the owner of this publication, Sunday nights at 7.00pm and Monday nights at 7.30pm.

See the rest here:

The Voice turns to technology to keep Boy George and Kelly Rowland on board - Sydney Morning Herald

Understanding How Magnet Nanoparticles Affect Cancer Cells in the Liver – Technology Networks

Posted on June 26, 2020 by Danzig

Scientists from the Immanuel Kant Baltic Federal University (IKBFU) and National University of Science and Technology "MISiS" have studied how magnet nanoparticles affect cancer cells in the human liver. In the authors' opinion, this research will help to treat oncology. The research results were published in the "Nano Convergence" Scientific Journal.

Because of their unique properties, magnetic nanoparticles can be used for therapeutic diagnostics and personalized treatment of cancer diseases, as well as be an effective contrast agent for MRI examination and imaging of tumors.

It is known that human cancer cells can absorb magnetic nanoparticles. This property can be used in cancer therapy in at least three ways: local heating of a tumor when exposed to a variable magnetic field (magnetic hyperthermia), targeted drug delivery, or selective cytotoxic effects of nanoparticles on cancer cells.

Scientists from the IKBFU Laboratory of Novel Magnet Materials studied the peculiarities of nanoparticles' influence on cell organelles and got acquainted with the peculiarities of intracellular processes in detail by using different lines of liver cancer cells. Small objects such as nanoparticles can be easily "eaten" by cells, but this does not always happen - in some cases, nanoparticles can damage the structure of a cell, penetrate it and kill it. By adding iron oxide nanoparticles of various shapes to the nutrient medium of cells, scientists were able to check the degree and nature of the changes in cell culture.

According to the authors of the study, the behavior of cancer cells depends on the concentration of nanoparticles in the solution and, most importantly, the type of cancer. The fact is that different cells respond differently to the same particles. This makes it possible to create an instrument based on nanoparticles, selectively suppressing cancer cells while keeping healthy cells intact.

Scientists have carried out experiments on how cancer cells in the human liver react to various types of magnet nanoparticles. They found that iron oxide nanocubes and nanoclusters are capable of activating certain genes that give a "self-destruct command" to liver cancer cells. This discovery sheds light on the mechanisms that regulate cell death caused by the cytotoxicity of nanoparticles.

Maxim Abakumov, co-author of the research, head of NUST "MISiS" Biomedical materials Laboratory said: "The mechanism of toxic effect is associated with the progressive permeability of lysosomal membranes in hepatocytes, which provokes the processes of apoptosis and autophagy, basically, "cell death".

According to Valeria Rodionova, the Head of the IKBFU Novel Magnet Materials Laboratory, the results of the research may be used for cancer diagnosis and therapy.

Valeria Rodionova told to RIA Novosti: "This interdisciplinary project brought together scientists from different fields: physics, chemists, and biologists. Our joint work allowed us not only to synthesize unique types of nanoparticles but also to analyze the mechanisms of specific cellular signaling pathways that they activate in the cell".

Cooperation in the scientific world often proves to be decisive in research. Thus, microscopic studies were carried out in the laboratory of biophysics, underthe supervision of Dr. Oleg Lunov, head of the laboratory (Institute of Physics of the Czech Academy of Sciences). Scientists of the Mendeleev Russian University of Chemistry and Technology also took part in the study.

Reference: Levada, et al. (2020) Progressive lysosomal membrane permeabilization induced by iron oxide nanoparticles drives hepatic cell autophagy and apoptosis. Nano Convergence DOI:https://doi.org/10.1186/s40580-020-00228-5

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Visit link:

Understanding How Magnet Nanoparticles Affect Cancer Cells in the Liver - Technology Networks

Boston Bans Use Of Facial Recognition Technology. It’s The 2nd-Largest City To Do So – WBUR

Posted on June 26, 2020 by Danzig

Boston has bannedthe use of facial surveillance technology in the city, becoming the second-largest community in the world to do so.

The city council unanimously voted on Wednesday to ban the use of the technology and prohibit any city official from obtaining facial surveillance by asking for it through third parties. The measure will now go to Mayor Marty Walsh with a veto-proof majority. Walsh's office said he would review the ban.

That move comes even as city officials say the technology isn't yet used by the Boston Police Department though the department could access those powers with a software upgrade.

Councilor Ricardo Arroyo, who sponsored the bill along with Councilor Michelle Wu, noted the technology is wildly inaccurate for people of color. A MIT study found that for darker skinned women, facial analysis programs had an error rate of up to 35%.

"It has an obvious racial bias and that's dangerous," Arroyo said ahead of the hearing. "But it also has sort of a chilling effect on civil liberties. And so, in a time where we're seeing so much direct action in the form of marches and protests for rights, any kind of surveillance technology that could be used to essentially chill free speech or ... more or less monitor activism or activists is dangerous."

During Wednesday's meeting and before the vote, Wu said that Boston shouldn't be using racially discriminatory technology. She noted the reports of the first known case of a man arrested after being misidentified by facial recognition technology in Michigan.

Were working to end systemic racism," Wu said. "So ending the ... over-surveillance of communities of color needs to be a part of that, and were just truly standing with the values that public safety and public health must be grounded in trust.

During a hearing earlier this month, Boston Police Commissioner William Gross said the current technology isn't reliable, and that it isn't used by the department.

"Until this technology is 100%, I'm not interested in it," he said.

I didnt forget that I'm African American and I can be misidentified as well," he added.

While the police department isn't using facial recognition technology now, an upgraded version of a video analysis software currently used by the department, called BriefCam, does have facial analysis power. Boston police said at a recent city council working session that it would not sign up for that part of the software update.

It's not clear whether the department has upgraded to the newest version of BriefCamor if the city has a current contract with the company. Boston police did not yet respond to questions about the contract.

Wu said government often chases new technologies and tries to put in regulations after the fact from ride-hailing to home-sharing. She said in this case, the disproportionate impact on people of color makes acting now even more important.

Councilor Kenzie Bok said during the council meeting that just because a technology is possible doesn't mean it should be used.

We really have a tendency in this country to let our technology go ahead of our common sense about how we want to live together," she said. "And thats why this to me is such a critical intervention for the council to be making in this moment.

Boston is now the second-largest city in the world to ban facial recognition technology, behind San Francisco. Five other Massachusetts communities have a ban: Somerville, Brookline, Northampton, Springfield and Cambridge.

The Massachusetts chapter of the American Civil Liberties Union pushed for the bans in those places, and is lobbying state lawmakers to act. There is no statewide ban, though a billthat would put a moratorium on face recognition systems is currently pendingbefore thejoint judiciary committee. The Boston ordinance would not affect private companies or federal agencies, like the FBI, from using the technology.

Kade Crockford, with the ACLU, said the state should act now to prevent harm down the line.

"Let's just ensure that we put the policy horse before the technology cart and lead with our values so we don't accidentally wake up someday in a dystopian surveillance state," Crockford said, "because behind the scenes, police departments and technology companies have created an architecture of oppression that is very difficult to dismantle."

The Boston city council ordinance notes governments around the world have responded to the COVID-19 pandemic with "an unprecedented use of surveillance tools" despite needing the public trust to effectively respond to the crisis.

Pentagon’s top technology officials resign | TheHill – The Hill

Posted on June 26, 2020 by Danzig

The Pentagons top technology official and his deputy are resigning next month,a Defense Department official confirmed on Tuesday.

Mike Griffin, the Pentagon's first undersecretary of research and engineering, and his deputy, Lisa Porter, will leave July 10, the official said.

The resignations were first reported byInside Defense.

Griffin, who took on the role in early 2018, and Porter said in a letter to staff that a private-sector opportunity has presented itself to us, offering an opportunity we have decided to pursue together,Defense News reported.

It has been a pleasure leading this great team over the past few years. We greatly appreciate your hard work, diligence, integrity, and devotion to technical excellence and technical truth in furtherance of the R&E mission, the two wrote, according to the outlet. We wish you all the very best.

Defense Secretary Mark EsperMark EsperTrump administration to extend troops at the border through 2021 Overnight Defense: Army to drop photos from soldier records to reduce racial bias | House defense bill backs B pandemic preparedness fund | Bill targets potential troop drawdowns House defense bill targets potential troop drawdowns in Africa, South Korea MORE on Wednesday confirmed the resignations and praisedGriffin and Porter's work.

"During their tenures, Dr. Griffin and Dr. Porter advanced critical work on the departments modernization priorities," Esper said in a statement. "They leave an office with a legacy of excellence in the research and development of technology that ensures American military advantage on land, at sea, in the air and in space. Mike and Lisa have my sincere thanks for their dedicated service to the department and the nation, and I wish them the very best as they enter this new chapter of their lives.

The two are the third and fourth officials to announce their resignation in the last week.

Kathryn Wheelbarger,the acting assistant Defense secretary for international security affairs,submitted her resignation on June 17,fivedays afterPresident TrumpDonald John TrumpTrump administration calls for Supreme Court to strike down ObamaCare Trump says there will be 'retribution' for those who deface monuments White House task force tracking coronavirus spikes even as Trump says virus is 'going away': report MOREpulled her name as the intended nominee to bedeputy undersecretary of Defense for intelligence.

And Elaine McCusker, the Pentagon's acting comptroller who questioned the Trump administration for its withholding of aid to Ukraine last year,submitted her resignationa day earlier after the White House in early March pulled her nomination for the official comptroller role.

--This report was updated on June 24 at 4:07 p.m.

See more here:

Pentagon's top technology officials resign | TheHill - The Hill

Exclusive: Viber severs ties with Facebook in growing boycott – The Guardian

Posted on June 26, 2020 by Danzig

The messaging service Viber, the fifth biggest with more than a billion users around the world, is severing all ties to Facebook as part of a growing boycott of the company by commercial partners.

The campaign, initially started in the US after Facebooks refusal to take action against posts from Donald Trump which critics said incited violence, has now grown to become an international movement.

Viber, owned by the Japanese conglomerate Rakuten, has its largest markets in eastern Europe, south-east Asia, and north Africa, and the companys chief executive, Djamel Agaoua, said the move to cut ties was prompted by Facebooks poor judgment in understanding its role in todays world.

On Wednesday, Viber pulled all advertising from Facebook and its sister app Instagram. Now, the company has begun the more labour-intensive process of removing all Facebook technology from Vibers own apps.

The company uses a number of Facebook tools, Agaoua said. Facebook Connect enables a login with Facebook button, common in apps and on websites across the world, while Viber also integrates with Giphy, an animated gif search engine that Facebook bought in May.

Its something that will hurt some of our users [who] like to use the Facebook Connect solutions to log in. Its hurt some of our marketing strategies, because they wont be able to use Facebook advertising to promote their campaigns. Its not an easy decision. Its not going to kill Viber, but it hurts, Agaoua said.

We are not the arbiters of truth, but the truth is some people are suffering from the proliferation of violent content and companies must take a clear stand.

Vibers decision comes as the advertising boycott which started the movement has also spread internationally. The UK arms of The North Face and Patagonia have both signed up to pull all advertising from the social network for the month of July.

For too long, Facebook has failed to take sufficient steps to stop the spread of hateful lies and dangerous propaganda on its platform, a Patagonia spokeswoman said. From secure elections to a global pandemic to racial justice, the stakes are too high to sit back and let the company continue to be complicit in spreading disinformation and fomenting fear and hatred.

Ben & Jerrys, the ice-cream brand known for its strong support for social justice, has also pulled its advertising from Facebook. But parent company Unilever, based in the UK, told the Guardian that while it supports Ben & Jerrys move, it has not yet committed to do the same.

As a global company, our approach has been and will continue to be to work in partnership to identify issues, offer solutions, and push for meaningful actions, a spokesperson for Unilever said.

While we have had some success and recognise the interventions our digital media partners have put in place such as establishing clearer community standards, comprehensive policies, protocols and third party audits, we know there is much more work to be done and we will be working with and pushing our partners to deliver the change that is needed.

More here:

Exclusive: Viber severs ties with Facebook in growing boycott - The Guardian

Common Food Additive Shown To Cause Adverse Health Effects – Technology Networks

Posted on June 26, 2020 by Danzig

A common food additive, recently banned in France but allowed in the U.S. and many other countries, was found to significantly alter gut microbiota in mice, causing inflammation in the colon and changes in protein expression in the liver, according to research led by a University of Massachusetts Amherst food scientist.

I think our results have a lot of implications in the food industry and on human health and nutrition, says lead author Hang Xiao, professor and Clydesdale Scholar of Food Science. The study confirmed a strong linkage between foodborne titanium dioxide nanoparticles (TiO2 NPs) and adverse health effects.

Along with colleagues at UMass Amherst and in China, Xiao published the research in Small, a weekly, peer-reviewed, interdisciplinary journal that covers nanotechnology.

Gut microbiota, which refers to the diverse and complex community of microorganisms in the gut, plays a vital role in human health. An imbalance of gut microbiota has been associated with a range of health issues, including inflammatory bowel disease, obesity and cardiovascular disease.

Human exposure to foodborne TiO2 NPs comes primarily from a food additive known as E171, which is made up of different-size particles of TiO2, including one-third or more that are nanoscale. E171, which makes products look whiter and more opaque, is found in such food as desserts, candy, beverages and gum. E171 exposure is two to four times higher in U.S. children than in adults, one study has found.

Smaller than 100 nanometers, foodborne nanoscale particles may have unique physiological properties that cause concern. The bigger particles wont be absorbed easily, but the smaller ones could get into the tissues and accumulate somewhere, Xiao says.

In their study, Xiao and his team fed either E171 or TiO2 NPs to two populations of mice as part of their daily diet. One population was fed a high-fat diet similar to that of many Americans, two-thirds of whom are obese or overweight; the other group of mice was fed a low-fat diet. The mice fed a high-fat diet eventually became obese, while the mice on the low-fat diet did not.

In both the non-obese mice and obese mice, the gut microbiota was disturbed by both E171 and TiO2 NPs, Xiao says. The nanosized particles caused more negative changes in both groups of mice. Moreover, the obese mice were more susceptible to the adverse effects of TiO2 NPs, causing more damage in obese mice than in non-obese ones.

The researchers found TiO2 NPs decreased cecal levels of short-chain fatty acids, which are essential for colon health, and increased pro-inflammatory immune cells and cytokines in the colon, indicating an inflammatory state.

To evaluate the direct health impact of gut microbiota disrupted by TiO2 NP, Xiao and colleagues conducted a fecal transplant study. They gave mice antibiotics to clear out their original gut microbiota and then transplanted fecal bacteria from the TiO2 NP-treated mice to the antibiotic-treated mice. The results support our hypothesis that including TiO2 NPs in the diet disrupts the homeostasis of the gut microbiota, Xiao says, which in turn leads to colonic inflammation in the mice.

The study also measured levels of TiO2 in human stool samples, finding a wide range. Xiao says further research is needed to determine the health effects of long-term such as life-long and multigenerational exposure to TiO2 NPs.

ReferenceFoodborne Titanium Dioxide Nanoparticles Induce Stronger Adverse Effects in Obese Mice than NonObese Mice: Gut Microbiota Dysbiosis, Colonic Inflammation, and Proteome Alterations. Xiaoqiong Cao Yanhui Han Min Gu Hengjun Du Mingyue Song Xiaoai Zhu Gaoxing Ma Che Pan Weicang Wang Ermin Zhao Timothy Goulette Biao Yuan Guodong Zhang Hang Xiao. Nano, Micro, Small, 09 June 2020, https://doi.org/10.1002/smll.202001858.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

View original post here:

Common Food Additive Shown To Cause Adverse Health Effects - Technology Networks

Blackfeet Nation calls for permanent protection of Badger-Two Medicine – The Cherokee One Feather – Cherokee One Feather

Posted on June 26, 2020 by Danzig

Tribe proposes legislation for sacred wildlands to be designated Cultural Heritage Area

Browning, Mont. Following decades of threat to their cultural homeland, the Blackfeet Nation on Thursday, June 25 released a legislative proposal to permanently protect the Badger-Two Medicine as a Cultural Heritage Area.

Weve been working on this for many years, with partners from all across the state, said John Murray, Blackfeet Tribal Historic Preservation Officer. The future of our traditional homeland has been uncertain for too long. Its time to protect the Badger-Two Medicine once and for all.

The Badger-Two Medicine is bordered by Glacier National Park, the Bob Marshall Wilderness Complex and the Blackfeet Indian Reservation. The 130,000-acre wildland was originally part of the Blackfeet Indian Reservation, and is considered sacred to the Blackfeet Nation. Today, it is managed by the U.S. Forest Service as part of the Helena-Lewis and Clark National Forest. The area is home to many Blackfeet origin stories, and Tribal members still practice traditional ceremony there.

In the early 1980s, the federal government illegally issued oil and gas leases in the Badger-Two Medicine over the objections of the Blackfeet Nation. Ever since, the Blackfeet and our allies have fought to prevent industrialization of the area. Last week, a panel of judges in the D.C. Circuit Court of Appeals canceled the last of those illegal leases. That decision has opened an opportunity to plan a better future for the Badger-Two Medicine, for Blackfeet, and for all Montanans.

The proposed Badger-Two Medicine Protection Act was drafted in partnership with Blackfeet leaders, non-tribal neighbors, hunters, anglers, conservationists, ranchers, local landowners and many others. In most ways, the proposal simply keeps things the way they are. It builds on existing protections, such as the areas Traditional Cultural District designation, and is modeled on legislation already enacted in other places. The proposal guarantees continued public access for hunting, fishing, hiking, camping, horse packing and other traditional uses. It also keeps grazing rights intact on the land.

Because the Badger-Two Medicine already is off-limits to oil/gas leasing and to motorized access, it has no impact on current status of those uses. Non-commercial timber harvest would continue under the proposal, for forest health, wildfire response and private property protection. And the plan would add protections for headwater streams that are an important source of clean water for agricultural operations and communities both on and off the reservation.

In addition to protecting traditional uses, the Cultural Heritage Area designation guarantees existing Treaty Rights will be honored, and establishes formal Tribal consultation with the U.S. Forest Service to contribute to future management decisions. The bill also provides the Blackfeet Nation an opportunity to conduct trail maintenance and other contracted forest work.

There are important voices that for too long have not been heard, Murray said, noting that during the recent legal proceedings there were no Blackfeet judges or attorneys in the courtroom. We have been refused a seat at our own table, and people across the country have been making decisions about our most sacred ancestral lands. This proposal provides us a voice in the discussion.

In addition, the proposal establishes a diverse citizen advisory group made up of both tribal and non-tribal stakeholders, to help the U.S. Forest Service draft long-term management guidelines for the Badger-Two Medicine.

This is not the first plan advanced to protect the area; multiple proposals for wilderness designation date back to the 1970s, and a Trump Administration review recommended creating a National Monument there in 2017.

But this is the first time in 40 years that we have been out from under the threat of industrial leases, said Terry Tatsey, a member of the Blackfeet Tribal Business Council. This is a real opportunity to get it right, once and for all. The Cultural Heritage Area plan is the first proposal to be written with Blackfeet involvement, and with Blackfeet values included.

According to Tatsey, Blackfeet owe our cultural survival to the Badger-Two Medicine. For all those decades, when the federal government outlawed our ceremonies, those mountains are where we went to practice our culture and our ways, he said. Its our last refuge.

Murray noted that Our traditional Blackfeet knowledge system is intact, but it is in a fragile condition. It cannot stand many more assaults. If we dont protect it now, we may lose those parts of Blackfeet knowledge and culture forever.

But the Badger-Two Medicine is not just home to the spiritual Medicine Grizzly; it also is home to flesh-and-bone grizzly bears, wolverines, elk, mule deer and many other iconic wildlife species that migrate between the Bob Marshall Wilderness Complex and Glacier National Park.

The Badger-Two Medicine represents some of the best wild habitat on the planet, said Tyson Running Wolf, a state legislator and former Blackfeet Councilman. This is where the prairie meets the mountains, and its some of the finest hunting heritage Montana has left.

That is one reason the proposal has the support of so many sportsmen, Running Wolf said. In addition to hunters and anglers, the Cultural Heritage Area plan is backed by a former oil lease holder, ranchers, business owners, conservation interests, large private landowners, outfitters and guides, and many others. Within Indian Country, it has been endorsed by Blackfeet Tribal Business Council, the Blackfoot Confederacy, the National Congress of American Indians, and the Rocky Mountain Tribal Leaders Council, which represents all the Tribes of Montana, Wyoming and Idaho.

Weve been talking to our neighbors for a long time about this, Running Wolf said, making sure were getting it right. Lots of people have provided advice, making it a better proposal for everyone.

Recently, the Blackfeet Nation shared the proposal with Montanas Congressional Delegation, with a request that they work together in a bipartisan manner to pass the measure as swiftly as possible.

A moment like this doesnt present itself very often, Murray said. With the leases canceled and the Forest Service seeking to manage the area in accordance with the existing Traditional Cultural District designation, were looking at a tremendous window of opportunity for everyone.

This land heals, and I think all of us could use some healing in the world right now, Murray said.

Blackfeet Nation release

View post:

Blackfeet Nation calls for permanent protection of Badger-Two Medicine - The Cherokee One Feather - Cherokee One Feather

The power of the Native American medicine wheel – Argus Leader

Posted on June 26, 2020 by Danzig

Richard P. Holm, MD, Prairie Doc Published 10:53 p.m. CT June 25, 2020

Rick Holm

In recent years, Ive learned of wonderful aspects of Native American culture, especially the sacred medicine wheel or hoop of life with variations in colors and meanings according to each tribe and nation. The circle is a universal spiritual symbol, but the Native American medicine wheel has complexity and power for me, a person who has cared for the elderly throughout my lifetime on the prairie.

For centuries, the Native American medicine wheel has given bearing, a sense of position, an objective and simultaneous understanding of both the infinitude and the limitation of life. The wheel brings a conscious spirituality that recognizes and accepts all things. For me, it closes the gap between the cynical scientific part of me and the inclusive spiritual part. By spiritual, I mean that part of our soul that savors music, art, poetry and the divine; the part that grows to love all things living and nonliving.

In the following verse, Ive taken the liberty to express my interpretation of the sacred circle:

First we get down on our knees and feel the soil, sacred Mother Earth, the world around us, the animals, plants, prairies, lakes, mountains, the environment of our planet from where all food and sustenance comes; earth is foundation.

Then we stand and raise our arms to sacred Father Sky, the sun, stars, clouds, rain, wind, air and breath of life, light and dark; from where all energy flows and ebbs; sky is infinity.

Then we turn and bow east, symbolized by the color red, the rising sun, springtime, birth, the very young, a sense of innocence and hope for the future.

Then we bow south, symbolized by the color yellow, the full sun, summer, early adulthood, a sense of unconquerable power and the courage to fight for justice.

Then we bow west, symbolized by the color black, the setting sun, autumn, mature adulthood, a sense of gravity to protect freedom and face vulnerability with honest eyes.

Finally we bow north, symbolized by the color white, nighttime, winter, old age, wisdom to savor friendship, family and the circle of life, release from fear of change and death, and a sense of empathy from having walked in anothers moccasins.

We pray in harmony as love consoles. O sacred hoop of life, please touch our souls.

This essay is a composite of works written by the late Richard P. Holm, M.D. who died in March 2020 after a battle with pancreatic cancer. He was founder of The Prairie Doc and author of Lifes Final Season, A Guide for Aging and Dying with Grace available on Amazon. Dr. Holms legacy lives on through his Prairie Doc organization. For free and easy access to the entire Prairie Doc library, visit http://www.prairiedoc.org and follow Prairie Doc on Facebook, featuring On Call with the Prairie Doc a medical Q&A show streaming on Facebook and broadcast on SDPB most Thursdays at 7 p.m. Central.

Read or Share this story: https://www.argusleader.com/story/news/brandon/2020/06/25/power-native-american-medicine-wheel/3262213001/

Originally posted here:

The power of the Native American medicine wheel - Argus Leader

The Human Genome Project transformed biology and medicine – The Economist

Posted on June 26, 2020 by Danzig

It is hard to remember what science was like beforehand

Jun 27th 2020

TWENTY YEARS ago, on June 26th 2000, those running the public Human Genome Project and its private-sector shadow, a firm called Celera Genomics, decided to declare victory. In a simultaneous breasting of the tape, each published a working draft of the genome. The broker, Bill Clinton, hosted the chief scientists at the White House. Hyperbolic comparisons were made to the Apollo project to land people on the Moon.

Unlike Apollo, though, this announcement marked a beginning rather than an end. Genomics is now so embedded in biology that it is hard to recall what things were like before it. Those first human sequences cost billions of dollars to obtain. Today, with the advent of new technologies, a full sequence costs about $200, and less detailed versions are cheaper still. It is as if, to use Apollo as the analogy, regular shuttles to the Moon had become available at prices an average family in the West could affordand the more adventurous might now be considering a trip to Mars.

Researchers with a hypothesis to test can, for instance, turn to biobanks containing details of tens or hundreds of thousands of peopletheir medical records, education, employment and, crucially, data about their genomes. Private companies will also sequence genomes to varying standards, for a suitable price. It is probably the case, and if not, it soon will be, that more than 1m human genomes have been sequenced by one method or another.

Genomics also helps non-medical biology. Many non-human species, including crops and domestic animals, have had their genomes sequenced. Though tinkering directly with the genes of organisms that end up on peoples plates still makes some a bit queasy, that is increasingly unnecessary. Genomic knowledge can now be used to speed up selective breeding, without the need for genetic engineering.

At the other end of the scientific spectrum, what can be done for Homo sapiens can be done, using DNA from fossils, for other (now extinct) species of human being: the Neanderthals and Denisovans. There is a possible practical interest even here. Sequencing shows that these species once interbred with Homo sapiens. It also suggests that the traces of that interbreeding which remain may help the recipient to fight off infections, by combating viruses and boosting the immune system.

Sources: INSDC; NHGRI; Broad Institute; S. Peyrgne et al., Science Advances, 2019; S. Mallick et al., Nature, 2016

This article appeared in the Graphic detail section of the print edition under the headline "Dawn of an era"

Here is the original post:

The Human Genome Project transformed biology and medicine - The Economist

Giving Tomatoes Their Shots: The Future of Plant Medicine May Come From Drones – DroneLife

Posted on June 26, 2020 by Danzig

Nobody likes getting a shot but even plants might need them sometimes. MIT researchers are exploring ways to administer injections to plants with drones.

As described in the original articleplants, much like people, get sick. The treatment traditionally involves the spread of chemicals designed to mitigate or alleviate the disease. Spreading or spraying chemicals usually results in much of the treatment being absorbed by the soil, rather than the plant.These researchers are testing a new type of needle that may be used in the future to shoot medicine into diseased plants directly, rather than spreading chemicals in the traditional method.

Science News for Students says: Similar to the way COVID-19 sickens and kills people, disease epidemics are wiping out entire groves of bananas,oranges and other crops. To treat plant diseases, farmers usually spray chemicals. Some of these target the germs that cause disease. Other chemicals target the pests that carry those germs.

But less than 5 percent [of the chemicals] go inside the plant, MIT researcher YuntengCao points out.

The more precise shot delivery method of giving plants medicine is called a phytoinjector. Its a tiny patch containing even tinier barbs that pierce the plant. Those barbs are microneedles. And theyre made to dissolve. As they do, they release their medicine. Later, the patch falls off or can be removed, says Science News.

A similar technology is already available for humans.

One of the major problems facing agronomists in using this technology is delivery- if the patches must be attached by hand to each individual plant, the technology may be impractical for large farming operations. Drones, already heavily used in agriculture, offer one possible solution. Researchers equipped a small drone with a toy dart gun in order to inject the needle into the plant see the enlarged video below.

CEO DroneLife.com, DroneRacingLife.com, and CMO of Jobfordrones.com. Principle at Spalding Barker Strategies. Has enjoyed working with and around the commercial drone industry for the last 10 years. Attendance and speaker at Industry Events such as Commercial UAV, InterGeo, Interdrone and others. Proud father of two. Enjoys karate, Sherlock Holmes, and interesting things. Subscribe to all things drone at DroneLife here. Email is [emailprotected] Make Sure that you WhiteList us in your email to make sure you get our Newsletter. [emailprotected]

Link:

Giving Tomatoes Their Shots: The Future of Plant Medicine May Come From Drones - DroneLife

Old is gold? Study finds 2,000-year-old medicine aiding in faster recovery among COVID-19 patients – Moneycontrol

Posted on June 26, 2020 by Danzig

As global pharma giantsrace to find the cure for coronavirus, the use of a 2,000-year-old medicine has shown signs of faster recovery among COVID-19 patients.

A test trial carried by Journal of American Medical Association (JAMA) on 105 Greek COVID-19 patients showed that the use of Colchicine, an anti-inflammatory drug prescribed for gout, has shown signs of clinical benefits.

Out of the 105 patients, 55 of them were given daily doses of colchicine for up to three weeks, alongside standard antibiotics and antivirals (but not remdesivir).

The test results reveal that participants who received colchicine had statistically significantly improved time to clinical deterioration. There were no significant differences in high-sensitivity cardiac troponin or C-reactive protein levels.

The health of the remaining 50 patients who did not receive colchicine clinically deteriorated to a severe stage.

While the drug has shown faster sign of recovery, doctors have stressed that the study size is too small.

Dr Rajiv Bahl, an emergency medicine physician in Orlando, said as per a report byMedical Express that the drug has been used to prevent heart conditions such as pericarditis and other inflammatory conditions affecting the body.

However, he believes the size of the trial is too small and more such studies need to be conducted for recommending colchicine as a routine drug to fight the coronavirus.

Although it does show some early promise, future studies need to be conducted before we can incorporate colchicine as an extensively used medication to help combat COVID-19," Bahl said.

Unlike many drugs being tested in hospital patients which are given by infusion or injection colchicine tablets are easy to take and are inexpensive.

Moneycontrol Ready Reckoner

Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.

WEBINAR: Tune in on June 30 at 11am to find out how term insurance can provide risk protection during tough times. Register Now!

Follow this link:

Old is gold? Study finds 2,000-year-old medicine aiding in faster recovery among COVID-19 patients - Moneycontrol

Podcast: Racism as a public health issue – Washington University School of Medicine in St. Louis

Posted on June 26, 2020 by Danzig

Visit the News Hub

This episode of Show Me the Science' focuses on racial disparities in COVID-19, as well as protests aimed at systemic racism

Wenners Ballard III, MD, a hospitalist and an instructor in the Department of Medicine, took part in the White Coats for Black Lives demonstration on the Washington University Medical Campus in June. Ballard is providing for acutely ill patients who are hospitalized with COVID-19.

A new episode of our podcast, Show Me the Science, has been posted. At present, these podcasts are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic.

In St. Louis, as in much of the United States, African Americans are more likely to test positive for COVID-19. Theyre also more likely to be hospitalized, to end up in intensive care and to die of the infection. Further, protests that have erupted against police violence point to another stressor shouldered primarily by African Americans.

Lee

In this episode, we discuss systemic racism inside and outside the health-care system and how the COVID-19 pandemic has propelled the issue to the forefront of our national consciousness. We speak with third-year medical student Kamaria Lee about her life as she studies to become a doctor during a time of massive protests and a pandemic. We also speak with Wenners Ballard III, MD. A hospitalist and an instructor in the Department of Medicine, he takes care of acutely ill patients in the hospital. These days, every one of his patients has been hospitalized for COVID-19. The majority also are people of color.

The podcast Show Me the Science is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.

[music plays]

Jim Dryden (host):Hello and welcome to Show Me the Science, a podcast about the research, teaching and patient care, as well as the students, staff and faculty at Washington University School of Medicine in St. Louis, Missouri, the Show Me State. My name is Jim Dryden, and Im your host this week. Weve been focusing these podcasts on the COVID-19 pandemic and Washington Universitys response. This week, we focus on race. In the St. Louis region, African Americans are four times more likely than members of other racial and ethnic groups to test positive for the coronavirus. And, as is the case in other parts of the country, theyre also more likely to be hospitalized, to be sent to an intensive care unit, and to die from the infection. But as weve all been reminded recently through the deaths of George Floyd, Breonna Taylor, Rayshard Brooks and others, COVID-19 isnt the only public-health issue having an impact on people of color. Well speak this week about race, public health, COVID and public demonstrations with third-year medical student Kamaria Lee.

Kamaria Lee:There is this decision that people, both inside and outside the Black community, are making of what is worse: putting myself out there and potentially getting COVID, or being silent. Everybody is still afraid, especially when we have had episodes of tear gas being sprayed, and people then are coughing and tearing and rubbing their eyes. So the fear isnt going to go away, but some people are saying, Enough is enough, and theyre kind of putting down their COVID fears to go out and protest.

Dryden:In fact, Washington University faculty, students and staff were recently among those at a White Coats for Black Lives event at the Washington University Medical Campus. Heres hospitalist Wenners Ballard.

Wenners Ballard III, MD:Were not going to stand for this. Enough is enough. And I think when you see health-care professionals, people that a lot of time you will put your life in their hands, standing up for a particular cause, it can resonate with people in a different way. And I think that touched me the most because a lot of times, you can feel like the world is against you and nobody does care. It touched people that saw the demonstration. And thats why we did it.

Dryden:In the earliest days of the COVID-19 pandemic, as it was becoming obvious that African Americans were getting sick and dying at very high rates, medical student Kamaria Lee, who is hoping to pursue health inequities research after she graduates, wrote about the viruss effects on the Black community, and in that essay, she said, Each time I lose more of my people, I lose a part of me.

Lee:There has been somewhat of a narrative in our idea that Blacks are perhaps inherently more unhealthy. But its a narrative thats tied to Blacks having a higher rate of chronic conditions. Its this idea that Blacks are more likely to have the whole list: hypertension or diabetes and things like that. And thats really offensive when that is used as the rationale or the reason why there is a higher death rate in the Black community in St. Louis and across the country. Because a lot of that is said with this blame on the Black community, that its our fault that were just inherently unhealthy, that we could have made better choices. When really, you have to look again at history, you have to look at systemic racism and say, What is it like to undergo racism and discrimination on a daily basis? How is it possible for someone, whether its microaggressions or something more overt, to experience these things chronically throughout their life and have it not affect their health? It does. It affects your health. It has this extra load on your body. And all of that affects baseline level of health, and then it also can be amplified as were seeing in a pandemic or with many other illnesses.

Dryden:And I want to know how thats affected you as you are pursuing your training.

Lee:Being a medical student and knowing that the data is out there, that Blacks have a higher death rate, are more likely to be hospitalized and infected with COVID-19, and also already having experienced what its like to be a Black medical student. There arent many Black students in higher education in general, and thats true in medical training as well. So already having experienced, what it feels like a special bond with the Black patients that Ive interacted with in the hospital due to a cultural congruence, perhaps in some cases, but not all, increased trust. And then hearing about this public health crisis, or rather living through this public health crisis, knowing that its those patients or patients who look like me who Ive already related to on a very deep level in the hospital that are some of those that are most affected. Even just the anxiety and the mental-health aspect of knowing that your community is being more affected is also something that theyre going through and a struggle that we share.

Dryden:And you wrote youve seen extra fear in your peoples eyes when theyre in the hospital and there are few, if any, clinicians who look like them. So you also say that you felt distrust even of you sometimes because, for some, that white coat makes you a part of the ivory tower. I want to know, can you talk a little bit more about that?

Lee:Yeah. I think its important to always know the historical context in which were working. Even for myself being a part of the community, educating myself on what happened before I was here. And so just looking back, we have, from the 1930s to the 1970s, the Tuskegee syphilis study, in which Black men were experimented on in order to see what would happen with untreated syphilis. So during that time, penicillin was seen to be a cure for syphilis, but the men were not told about that, and their syphilis continued to be untreated, which is completely unethical and horrifying. There are also instances of Black bodies being robbed from graves to be used during medical dissections historically. And so not everyone in the Black community knows all of this historical detail. Some do, but some of that history is a part of the distrust. Or even more recently, segregation hospitals or knowing that your life isnt seen as the same when you walk into the health-care system because you were taken to a different hospital and some clinicians wouldnt allow you into their clinic. So all of that has created a long history and a reasonable history of distrust of, yeah, white clinicians, non-Black clinicians, but also the system. And a part of me being a clinician means that my identity is multiple things. Im a Black woman, but Im also part of the health-care system. And so sometimes skin color or even the same culture, a similar background, isnt enough to kind of negate the distrust that, like I said, is rightfully there for many reasons.

Dryden:Is this a good time to be a medical student? I mean, obviously the pandemic affects the rotations that you can do, your interaction with patients. On the other hand, this is a once-in-a-century sort of public-health crisis combined now with a public-health crisis thats been going on in the United States for at least 400 years.

Lee:Going to medical school now with the COVID-19 pandemic and with the current changes that were seeing, more people in society want to make towards or against racism. I think a lot of people in the Black community and other minority communities have been pushing for people to realize how bad racism is, which sounds silly because its been going on for decades and hundreds of years. But I feel like there has been this hope for others and enough of other people to finally be fired up to make change. And I think that while its not changing everyones minds and some people are more cynical about how much change can actually be made, I think its a critical moment for people in medical school to understand that you need to acknowledge racism and be actively working against racism in order to be an adequate clinician.

Dryden:When you finish medical school, somebodys going to make a speech and say to you and your classmates that youre part of the future, you will write the future. But you wrote in your essay that its hard not to be intimidated by the enormity of the problem here. So how can you and your classmates make that future different and better?

Lee:One thing I recently encouraged my classmates to do is to all put health inequity research as something that they do. Or if theyre interested in research, health equity advocacy is something that they do. I have a bachelors in sociology from college. And like I said, right now and in the future, I hope to continue health inequities research. And while its great that I can define myself that way and say, This is who I want to be in my academic career, its actually sad that I can define myself that way because it should just be something that all clinicians are doing. It shouldnt be a distinguishing factor. It should be, Im in the medical field. Ive taken an oath. And Im here to fight against inequities, fighting against racisms effects on health. And so thats something that I really hope my classmates will all do, is define themselves the same way I have defined myself so that its not actually a unique way to go about their careers.

Dryden:Several WashU physicians, others recently, that participated in the White Coats for Black Lives. What message was sent that day, and does it relate in any way to the inequities that you see regarding COVID-19?

Lee:I think it represents an intent, it represents an action. But as far as how large the issue is of racism and how significant racism is as a threat to public health, as weve seen with the police brutality or just several unjust murders, its a very small step. It is up to everyone, regardless of their race or ethnicity or their own background or privilege, to walk in what they did at the protests every single day. To be more cognizant of how they are treating their patients, to understand, Maybe if Im not from the same culture, that doesnt mean there is no chance of relating, and so to at least try. There is a lot of things that need to happen in the micro-level within each patient interaction, with interactions of all of their trainees, as well as in their own personal lives and how they raise their children. And so something thats a powerful image can represent intent and hopefully represents a promise. But its a very small step in what actually needs to be done both by individuals and at institutional levels. But some people are saying, Enough is enough and are kind of putting down their COVID fears to go out and protest.

Dryden:One of those young African Americans wearing a white coat was Wenners Ballard III. Hes a hospitalist at Washington University and Barnes-Jewish Hospital in St. Louis. That means he takes care of acutely ill patients in the hospital. And for the last several weeks, that has meant patients who have COVID-19.

Ballard:Ever since this really ramped up in about late February or early March, Barnes dedicated a certain group of physicians to only taking care of COVID patients to sort of limit the exposure to a lot of physicians. And I was one of those.

Dryden:Is that a scary thing from your perspective, or does it mean that there are certain folks in your life that you cant see because youre taking care of these patients?

Ballard:I dont know if I would call it scary. Its definitely in the back of your head where you do hear of younger people catching this and having poor outcomes. But its definitely a lower mortality rate in people in my demographic age group-wise. But it is still worrisome. And I wasnt able to my dad has multiple myeloma and hes currently on chemotherapy, so I wasnt able to go back and see him, where I probably otherwise would have. So in that way, it did affect me. But you kind of put all that to the side when you see how many people are affected and kind of need your help. It just feels like your calling and this is what you did all this for in the first place. So you kind of step up to the plate and dont really think about the other things.

Dryden:African Americans have been hit harder than many other communities. Is that what youve experienced on the floors at Barnes-Jewish?

Ballard:Absolutely. Definitely, African Americans have been hit disproportionately by COVID, especially in St. Louis. I think when you look at the statistics across the nation, what youre seeing is African Americans being disproportionately affected, but specifically African Americans that live in certain parts of the country. So for instance, if you look at New York, which is kind of the epicenter for all of this, people that lived in certain counties in New York City had a threefold higher rate of infection and a sixfold higher rate of dying. If you look in cities like Chicago thats much closer, the infection rate among African Americans, I believe, was around 50%

Dryden:Meaning that 50% of the COVID cases in Chicago involved African Americans.

Ballard: And the mortality rate among African Americans was around 70%, but they only make up 30% of the population in Chicago. Its mostly centered around on the south side of Chicago. So it has a lot to do with socioeconomic status.

Dryden:These racial disparities are not unique to COVID-19, correct?

Ballard:They are not. And I think its interesting I was actually thinking about this the other day I think COVID-19 kind of pulled back the shade a little bit and showed us like, Wow, these health disparities are real, and theres something that really needs to be done about it. Sort of like how when everybody saw that video of the knee on his neck, people said, Wow, enough is enough. Theres something that we need to do about it. And youre seeing some change occur already. I hope that same thing will happen in the health-care community and we start to do more things to try to bridge the gap. When you arent able to do social distancing because you work at the local grocery store, you work at the gas station, you work at places where youre not able to work from home, youre not able to telework, youre not really able to social distance. And also, when you live in these areas, the household density is higher, meaning theres a lot more people under one roof. And I think St. Louis is a prime example, when you look at the Delmar Divide, weve known about these health-care disparities for a very long time. I had a lady that was 50 years old. She had no medical co-morbidities. And she could not stop going to work because if she did, her lights would be cut off, her waters going to get cut off. She got COVID. She ended up on the highest form of life support we had called ECMO. Ultimately, she did walk out of the hospital. And she is one of the very rare cases that we see. And she almost didnt make it. And its just very shocking to see a 50-year-old thats otherwise very healthy that probably could have avoided this if she could have teleworked, if she had been able to not worry about her lights, if she had, you know, a lot of things.

Dryden:What can medical professionals and the health-care community in general do about this at the moment? Well, you know, on the George Floyd issue, we can say, Well, lets take some steps to monitor police in different ways. On the health-care front, what can someone like you do?

Ballard:Its complicated, and its going to take a lot and a long time, but I think what we can start doing right now is working on our own implicit biases, kind of addressing how we look at each individual patient. So I know a lot of times colleagues of mine walk into a room and see a particular patient and adjust the way they speak to them or adjust their expectations of how that interaction is going to go. I think sometimes people and I dont think people do it maliciously, honestly. I think its just because of lack of knowledge and lack of exposure. I dont think people should be ashamed to say that they dont really know how to go about these interactions or how to make sure somebody is understanding what theyre saying. Educating our patients more is a big part of this. Thats something that we can do every day when we walk into a patients room. And I think doing our best to check our biases at the door is another big thing that we can do right now. I mean, its something that we definitely need to start doing, but we also need to work on a bigger change in the country overall.

Dryden:You recently attended the White Coats for Black Lives event. What motivated you to do that? And what message were you, and the other physicians and health-care workers participating trying to send?

Ballard:I think the message that were trying to send is, overall, one, solidarity and unity and standing up for whats right and showing the people in this country and the rest of the world that were not going to stand for this, enough is enough. And I think when you see health-care professionals, people that a lot of times you will put your life in their hands, standing up for a particular cause, it can resonate with people in a different way. And I think, when I saw a lot of the people driving by, it was very interesting to see the varying reactions. There were some people in tears just being so touched by it, some people honking their horns, clapping, cheering. Some people scowling. Some people yelled out some things as they drove by. What I saw overall was overwhelming support. And I think that touched me the most. Because a lot of times you can feel like the world is against you and nobody does care, but to see that amount of people in that position caring that much, that they walk out of their jobs, they stand on the street, they hold up signs, they kneel for 8 minutes and 46 seconds, to see that many people doing that in that profession, it touched me. So I know that it touched people that saw the demonstration. And thats why we did it. We did it to show that this cant keep happening and its not going to keep happening and were going to do something about it.

Dryden:People were wearing masks. They were socially distancing. When you see some of the other protests where maybe masks arent as ubiquitous and where maybe people either by choice or because theyve sort of been corralled by police are very close together, does that worry you as the guy that might be treating some of these folks?

Ballard:Absolutely. Absolutely. Because of course, a lot of the people at these protests are 50 and younger. You would probably be asymptomatic if youve got it, honestly, or have mild symptomatology from it, but you could pass it on to somebody thats not. So I think it is important that people do, especially for the time being, keep their masks on. Especially at these protests, we get really excited, were loud, I think it is important to try to social distance as best you can and wear a mask. And if you do that, then dont let it deter you, and get out there. Get your message across. Thats also important because theyre both health-care crises.

[music plays]

Dryden:Ballard and Lee say many things must change to address the health-care disparities that put people of color at greater risk for COVID-19 and other illnesses. And both say theyre committed to becoming part of the solution and encouraging their colleagues in medicine to do the same. Show Me the Science is a production of the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis. The goal of this project is to keep you informed and maybe teach you some things that will give you hope. Thanks for tuning in. Im Jim Dryden. Stay safe.

Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

See the original post here:

Podcast: Racism as a public health issue - Washington University School of Medicine in St. Louis

Holland recalls his ‘greatest years’ in the Hat – Medicine Hat News

Posted on June 26, 2020 by Danzig

By RYAN MCCRACKEN on June 26, 2020.

rmccracken@medicinehatnews.com

When Ken Holland picked up his phone Wednesday to find Lanny McDonald was calling, he was initially a bit confused.

However, it didnt take long for Holland to realize that the only Medicine Hat Tigers alumnus ever inducted into the Hockey Hall of Fame was calling for a reason hes no longer the only one.

Briefly I was wondering why Lanny called, then I got the news. Lanny told me I was one of the newest members of the Hockey Hall of Fame, Holland said in a Wednesday conference call with media. Really, it hasnt sunk in yet, and I think its going to take a while to sink in. I think back to growing up in Vernon, B.C. and playing minor hockey and Tier 2 junior hockey. I really was just a backup goalie in Tier 2 and made the Medicine Hat Tigers, and then today to get the call that Im going into the Hockey Hall of Fame. You think about all the great people, the great players and all the great people who have played the game, and what a wonderful game this is.

Holland now working as general manager and president of hockey operations with the Edmonton Oilers was inducted as a builder alongside players Jarome Iginla, Marian Hossa, Kevin Lowe, Kim St. Pierre and Doug Wilson.

McDonald has been playing Santa Claus by making calls to induct hockeys all-time greats ever since being named HHOFs chairman of the board in 2015, but Wednesday was the first time it had him recalling his years in Medicine Hat alongside another former Tabby.

Medicine Hat was probably the best time of my life, said McDonald, who racked up 112 goals and 141 assists as a member of the Tigers from 1971-73, and became the first player in team history to have his number retired. Medicine Hat had such a great following of fans, and in the second year to be able to go to the Memorial Cup was pretty phenomenal. I met my dear wife, Ardell. Weve been married now for 45 years, so I owe a lot to Medicine Hat.

Its a feeling shared by Holland as well. The 64-year-old Vernon product also met his wife, Cindi, while competing with the Tigers, and says his experiences in the Gas City helped shape his future in the game.

Im like, Lanny, those were two of the greatest years of my life,' said Holland. It really was the opportunity for me to start my career. If I didnt make the Medicine Hat Tigers I would never have had an opportunity to go on and play pro hockey for nine years and meet the people I did along the way.

After earning a place on Medicine Hats roster for the 1974-75 season, Holland went on to record a 4.05 goals against average over two years and 78 games with the club before moving into a nine-year professional career.

It was certainly a springboard for me to be able to go on and play pro hockey, then to stay in the game once my career ended, said Holland. Some of the players that I played with (in Medicine Hat) are still some really good friends of mine today Don Murdoch, Brian Hill, Gary Gilchrist, Ron Areshenkoff, who was in my wedding party and unfortunately just passed here a few months ago.

It was after hanging up his skates following 343 games in the American Hockey League as well as stints in the NHL and International Hockey League that Holland shifted his focus to the management side. But he almost ended up selling vacuums.

I played nine years of pro and I wasnt sure what I was going to do, said Holland. My mom had suggested getting an Electrolux vacuum cleaner job. Then a couple days later Jim Devellano called and offered me the job as a scout for the Detroit Red Wings, and here I am today getting the call from Lanny and being with this incredible class of the 2020 induction. Funny how life goes.

The rest is hall-of-fame-worthy history. Holland took on his new role as scout with the Red Wings in 1985, then after helping the Wings win the 1997 Stanley Cup as an assistant general manager, was promoted to GM in Detroit. He went on to win the Cup three more times in 1998 for back-to-back titles, then again in 2002 and 2008 while winning more combined regular season and playoff games than any other NHL team during the stretch.

In May of 2019, Holland opted to part ways with the Red Wings after 22 years, and returned to Alberta to take on his role as general manager and president of hockey operations for the Oilers.

I was so fortunate that we had so many great players (in Detroit), and to work with Scotty Bowman and Jim Devellano and Mike Babcock, the list goes on and on, of talented people that I got to work with. Jim Nill running the draft, he said. I feel incredibly fortunate today, but I also know that I received the call from Lanny today and really there were so many people who did all the work in Detroit. I got to go up to the mic and make some announcements, but there were a lot of people who were doing the work.

You must be logged in to post a comment.

Continued here:

Holland recalls his 'greatest years' in the Hat - Medicine Hat News

Five things we learned from Penn Medicine innovation guru Roy Rosin – The Philadelphia Citizen

Posted on June 26, 2020 by Danzig

Philadelphia is riddled with problems. We know this, of courseits what guided the creation of The Philadelphia Citizen and its focus on championing solutions.

In a fascinating conversation on Wednesday night between Citizen co-founder Larry Platt and Penn Medicine Chief Innovation Officer Roy Rosin, it became apparent to the nearly 250 guests in attendance that you cant solve any problemwhether its reinventing razors or tackling the challenges of a pandemicwithout asking the right questions, and corralling the right experts.

[People] cant reveal to you the solution very often. You have to get deeply embedded and just see everything and see all the things that they cant articulate or cant remember or are not even aware of, Rosin said. Once you get that deep into what the problem is, you can generate a whole bunch of different directions.

Over the course of the hour-long event, Rosin made clear that he believes deeply in the potential for Penn Medicineand the people who work thereto solve some of the biggest obstacles facing our city, including most recently when the Covid-19 pandemic hit.

From the time I walked in the door at Penn eight years ago, what I found consistently were people who support the idea of making things better, he said. These are mission-driven individuals who want to make the world a better place.

If you missed the chat, you can watch the full interview here (weve even edited out the technical glitches!). Or keep reading to find a handful of the many insightful takeaways we gleaned from the man Platt once dubbed the smartest person in Philadelphia you havent heard of.

1. He focuses on how not can

On innovating, Rosin said its more transformative to ask how can we do something, versus can we do this. When you ask the latter, youre likely to get a nobut when you ask how, you open the door to progress. If thats not a mantra we should all adopt, what is?

2. Hes got passion in spades.

Its clear that passion and compassion drive Rosins work. Yes, he has a Harvard degree in economics, an MBA from Stanford and nearly two decades of experience in Silicon Valley under his belt. But the health care sphere is so clearly where hes meant to be.

Just one example: When an event attendee asked Rosin for insight on how to improve doctor-patient communication, Rosin talked about the importance of finding the right doctor, making sure the time spent together is being used well, being part of a health care system where doctors use electronic consults during office visits to connect with specialists (and thereby fast-track the answer-getting process for patients).

And he acknowledged that theres no silver bullet to solving the problem. When the questioner divulged that she personally lived with health issues related to a rare birth defect, he offered to talk to her after the event to help her find a Penn doctor who could help. It was a poignant moment, the likes of which you dont typically see in online events with experts.

I dont want to oversimplify, he said. When you have a complex chronic disease [] it really takes a special person to work with you and work with you carefully. Luckily the clinicians I work with are these wonderful, mission-driven people who put in the nights and weekends to do that kind of thing. You find the right one, and great things happen. [There are] people who are just brilliant physicians, and Ill see if I can connect you with one of those people.

3. No crazy ego here.

Rosin took advantage of every opportunity to credit his Penn colleagues and sing their praises, over his. Its an admirable leadership trait, and one that Rosin mightve picked up during the 18 years he worked at Intuit under the tutelage of legendary leaders like Scott Cook and the late Bill Campbell.

Bill was an incredible leader, he was an incredible people person. And I think his success in some ways was because so much of business is about humans. Business is fundamentally human. [] Any one of us wouldve followed him up any mountain that he told us to charge. He made us feel special, he made us feel important, he paid attention to me before I deserved it, he said

4. Hes not an early tech adopter.

He may have the word innovation in his title but, no, he doesnt have every new gadget, or robots serving him meals at home.

Im like the last person to adopt new technology nowadays, he said, conceding that hes the only member of his team not on Slack. (I probably drive my team crazy not being on it.) But, as he explains in the video, an advantage to being somewhat of, well, a luddite:

One of the things that I actually think helped me in Silicon Valley was my ignorance. I was willing to ask dumb questions. Im willing to say when I dont understand things. I frequently dont understand things. But I try to think through them logically and try to make sense of it, and being a non-expert actually helps people who are truly experts to sometimes step back and say wait a minute, Im seeing that through a new lens, Im seeing that through new eyes, he said. Sometimes it is that ability to be a little bit behind that doesnt harm you so much and it does sort of start an interesting conversation.

And even though he doesnt have the glitziest toys, he of course appreciates and celebrates technology. I think technology is the only way we really scale innovation. Its very hard to scale new things without technology underneath it. So Im obviously a big fan of technology.

5. He believes the word innovation is hackneyed.

Its probably the most overused word out there these days. Its one of those words that because it now means everything, it means nothing, he said. I find myself being drawn more to terms like creative problem-solving than innovation just because it is such a beaten-up, overused word nowadays.

And he made clear that the way to creatively solve for any problem is to start by listening. Deeply.

Read this article:

Five things we learned from Penn Medicine innovation guru Roy Rosin - The Philadelphia Citizen

Covid-19 treatment: Medicines being used for treating coronavirus patients in India – Livemint

Posted on June 26, 2020 by Danzig

Covid-19 is a new disease and there is no drug or vaccine for it as of now and the patients are being given medicines that were approved for treating other viral infections. At least five medicines have either been given a go-ahead from the government to treat coronavirus infected patients in India or are in the final stages of the trial being carried out. India has also been using hydroxychloroquine (HCQ), an antimalarial drug, for treating Covid patients. Coronavirus positive cases in India are increasing at an alarming rate. With the highest single-day spike of 16,922 cases on Thursday, India's Covid-19 count reached 4,73,105. It is the fourth worst affected country, only behind USA, Brazil and Russia.

The treatment protocols for coronavirus are being revised from time to time based on emerging evidences. Here are the drugs, treatment presently available for coronavirus (Covid-19) and what we so far know about them:

1) Hydroxychloroquine (HCQ): It was first developed in India for the treatment of malaria. Two Indian firms, Ipca Laboratories and Zydus Cadila Ltd, are the worlds largest manufacturers of the drug. The Indian Council of Medical Research has also been using the drug to prevent infection among healthcare workers based on theoretical evidence that hydroxychloroquine does not allow the novel coronavirus, or SARS-COV2, to attach to cells. HCQ was touted as a potential coronavirus treatment by US President Donald Trump and some other global political leaders.

2) Covifor: The Drug Controller General of India (DCGI) has given approval to Hetero for manufacturing Remdesivir for the treatment of Covid-19. Heteros generic version of Remdesivir will be marketed under the brand name Covifor in India. It has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of Covid-19 in adults and children, hospitalized with severe symptoms of the disease. Covifor (Remdesivir) will be available in 100 mg vial (injectable) which has to be administered intravenously in a hospital setting under the supervision of a healthcare practitioner.

3) Fabiflu: Glenmark Pharmaceuticals has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of mild to moderate Covid patients. Priced at 103 per tablet, the prescription-based drug will be available as a 200 mg tablet at an MRP of 3,500 for a strip of 34 tablets.

4) Cipremi: Cipla has launched its own remedesivir under the name of Cipremi. Cipla said it will be commercialising remdesivir through its own facilities and partnered sites. The drug will be supplied through government and open market channels, to ensure equitable distribution. The drug is most effective on those who need oxygen support. Cipla is yet to disclose the pricing for the drug.

5) Methylprednisolone: Indian doctors have been successfully using Methylprednisolone in handling moderate to severe cases of the disease. It reduces its overall mortality and is a more essential part of the treatment regimen. Also, it reduces the severity of symptoms, doctors claimed. Dexamethasone is supported by a large trial and is a cost-effective drug. It is of the same group as Methylprednisone.

Subscribe to newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Original post:

Covid-19 treatment: Medicines being used for treating coronavirus patients in India - Livemint

MHC likely going part online, part in person – Medicine Hat News

Posted on June 26, 2020 by Danzig

By MO CRANKER on June 26, 2020.

mcranker@medicinehatnews.com

Classes this fall at Medicine Hat College are going to look much different compared to previous years.

College faculty members are preparing classes to be delivered in a combination of in-person and online formatting.

Weve been working for the last five or six weeks to figure out how exactly we will deliver our programs in the fall, said vice president academic and provost Vicky Roy. Weve been working hard with faculty and management to determine how many students we can have in classes for certain courses.

Roy says a number of classes will be shifted to an online format, while others have a mix of online and in-person learning.

Something like business, we are able to offer online this fall, she said. A health-care or nursing program, or something in the trades will be more of a blended format. We want practical components to be face-to-face when it is safe.

Roy says faculty is doing its best to make the fall semester happen.

Teachers are working really hard to get everything online, she said. We want to make sure all of the programs are student-friendly, flexible and inclusive.

Of course this is a challenging time, but we are prepared to deliver education in the fall.

More information on fall class formatting can be found on the MHC website under the Programs tab.

Program rollout for the winter will be evaluated at a later date.

You must be logged in to post a comment.

Legal Marijuana Market to Witness Huge Growth by 2028 | Medicine Man, Canopy Growth, Aphria – Cole of Duty

Posted on June 26, 2020 by Danzig

Global Legal Marijuana Market Report is an objective and in-depth study of the current state aimed at the major drivers, market strategies, and key players growth. The study also involves the important Achievements of the market, Research & Development, new product launch, product responses and regional growth of the leading competitors operating in the market on a universal and local scale. The structured analysis contains graphical as well as a diagrammatic representation of worldwide Legal MarijuanaMarket with its specific geographical regions.

[Due to the pandemic, we have included a special section on the Impact of COVID 19 on the @ Market which would mention How the Covid-19 is Affecting the Global Legal Marijuana Market

Get sample copy of report @jcmarketresearch.com/report-details/52274/sample

** The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you.

Global Legal Marijuana(Thousands Units) and Revenue (Million USD) Market Split by Product Type such as Indoor Indoor Greenhouse

The research study is segmented by Application such as Laboratory, Industrial Use, Public Services & Others with historical and projected market share and compounded annual growth rate.Global Legal Marijuana by Region (2019-2028)

Geographically,this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Legal Marijuanain these regions, from 2012 to 2022 (forecast), covering

Additionally, the export and import policies that can make an immediate impact on theGlobal Legal Marijuana Market. This study contains a EXIM* related chapter on the Legal Marijuanamarket and all its associated companies with their profiles, which gives valuable data pertaining to their outlook in terms of finances, product portfolios, investment plans, and marketing and business strategies. The report on theGlobal Legal Marijuana Marketan important document for every market enthusiast, policymaker, investor, and player.

Key questions answered in this report Data Survey Report 2028

What will the market size be in 2022 and what will the growth rate be?What are the key market trends?What is driving Global Legal Marijuana Market?What are the challenges to market growth?Who are the key vendors inspace?What are the key market trends impacting the growth of theGlobal Legal Marijuana Market?What are the key outcomes of the five forces analysis of theGlobal Legal Marijuana Market?

Get Interesting Discount with Additional Customization@jcmarketresearch.com/report-details/52274/discount

There are 15 Chapters to display theGlobal Legal Marijuana Market.

Chapter 1, to describe Definition, Specifications and Classification ofLegal Marijuana, Applications of Legal Marijuana, Market Segment by Regions;

Chapter 2, to analyze the Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;

Chapter 3, to display the Technical Data and Manufacturing Plants Analysis ofLegal Marijuana, Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;

Chapter 4, to show the Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);

Chapter 5 and 6, to show the Regional Market Analysis that includes North America, Europe, Asia-Pacific etc., Legal MarijuanaSegment Market Analysis by Indoor Indoor Greenhouse ;

Chapter 7 and 8, to analyze the Legal MarijuanaSegment Market Analysis (by Application) Major Manufacturers Analysis of Legal Marijuana;

Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Indoor Indoor Greenhouse , Market Trend by Application Recreational Medical ;

Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;

Chapter 11, to analyze the Consumers Analysis of Legal Marijuana;

Chapter 12, to describe Legal MarijuanaResearch Findings and Conclusion, Appendix, methodology and data source;

Chapter 13, 14 and 15, to describe Legal Marijuanasales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Select license versionand Buy Full Research Report: @jcmarketresearch.com/checkout/52274

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:JCMR global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the Accurate Forecast in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their Goals & Objectives.

See the article here:

Legal Marijuana Market to Witness Huge Growth by 2028 | Medicine Man, Canopy Growth, Aphria - Cole of Duty

UBC faculty of medicine researchers receive nearly $14M in federal funding for COVID-19 research – UBC Faculty of Medicine

Posted on June 26, 2020 by Danzig

Researchers at UBCs faculty of medicine have received a combined total of $13.8 million in grants in the latest round of funding from the federal government in support of research aimed at addressing the health challenges of the COVID-19 pandemic.

In total, 19 teams at UBC working in drug research, global health, obstetrics, medical imaging, public health, and Indigenous health are receiving support as part of a $109-million investment in research projects by the federal government, focused on accelerating the development, testing, and implementation of measures to mitigate the rapid spread of COVID-19 and its negative consequences on people, communities, and health systems. Among the 19 UBC projects, 17 are being led by researchers from the faculty of medicine.

This new federal investment will enable UBC researchers to further contribute valuable insights into medical and societal responses to COVID-19, said Gail Murphy, vice-president, research and innovation at UBC. These research projects, which range from developing treatments to addressing the impacts of COVID-19 on vulnerable and marginalized populations, could have national and global impacts, and we are grateful for this support.

The UBC-led projects being supported by this funding range from the creation of an integrated rapid-response network for emergency departments across Canada and the development of genetic libraries, to research into the dual health emergencies of overdose and COVID-19 and studies into the long-term effects of COVID-19 on brain health.

The Government of Canada is providing the funding for this research through CIHR and the International Development Research Centre (IDRC), in partnership with Alberta Innovates (AI), Michael Smith Foundation for Health Research (MSFHR), Research Manitoba (RM), Research Nova Scotia (RNS), Saskatchewan Health Research Foundation (SHRF), and the New Brunswick Health Research Foundation (NBHRF).

Research findings and data produced as a result of the funding will be shared rapidly and openly (in line with the joint statement on sharing research data and findings relevant to the novel coronavirus outbreak) to inform the global public health response and to help save lives.

Below is a list of the UBC faculty of medicine projects receiving funding:

An international consortium of researchers led by Dr. Artem Cherkasov, professor in the department of urologic sciences and senior scientist at the Vancouver Prostate Centre and the Vancouver Coastal Health Research Institute, and Dr. Franois Jean, associate professor in UBCs faculty of science department microbiology and immunology, is receiving $2.1 million from CIHR to use artificial intelligence to search for SARS-CoV-2 inhibitors among known drugs. They will work to identify antiviral drugs that can work synergistically with antiviral therapy remdesivir to boost its effectiveness and block SARS-CoV-2, similar to the drug cocktails used in treating HIV and hepatitis C infections. This research will be performed at UBC FINDER, one of the largest university-based containment level 3 facilities in the world, founded by Dr. Jean.

Dr. Pieter Cullis, a professor in the faculty of medicine at UBC and researcher at Djavad Mowafaghian Centre for Brain Health, is receiving $237,445 from CIHR towards developing an antibody therapy for COVID-19. The study will use lipid nanoparticles to carry genetic instructions for the antibody to the liver, resulting in the secretion of antibodies that target the SARS-CoV-2 virus. Dr. Cullis predicts that this therapy, which could protect healthcare workers from infection and treat patients infected with the virus, would be a candidate for clinical testing within one year.

A team led by Dr. Soren Gantt, associate professor and head of the division of infectious diseases in the department of pediatrics at the UBC, is receiving $450,635 from CIHR to study and track the household transmission of SARS-CoV-2 in Africa. His team will examine patterns of SARS-CoV-2 transmission among children and adults in an established cohort of >200 households in Nairobi, Kenya, to garner insight into the global COVID-19 pandemic, and guide public health interventions in resource-limited settings.

Dr. Kurt Haas, professor in the department of cellular and physiological sciences at UBC, is receiving $172,414 from CIHR to examine how different genetic variants of the human ACE2 protein interact with the spike protein on the COVID-19 virus, SARS-CoV-2. Researchers in the Djavad Mowafaghian Centre for Brain Health will create genetic libraries of ACE2 variants, and test how the SARS-CoV-2 binds to them, which is how it infects host cells. Results may identify genetic contributions to disease expression, and this library will be available to test emerging drug therapies and aid efforts to develop novel therapeutics.

Dr. Corinne Hohl, associate professor in the department of emergency medicine and scientist at the Centre for Clinical Epidemiology and Evaluation and the Vancouver Coastal Health Research Institute, is receiving $2.5 million from CIHR to develop national standardized data collection, assessment and treatment protocols for COVID-19 in emergency departments. The ED Network will harmonize data collection across Canada and develop, evaluate and implement clinical decision rules for COVID-19 patients in emergency departments. The project is also receiving $250,000 from Genome BC and $75,000 from the BC Academic Health Sciences Network.

A team led by Dr. Rodney Knight, assistant professor in the department of medicine, is receiving $187,064 from CIHR to examine how public health measures, such as social distancing, affect the longer-term social and health of youth under 30. Researchers in Canada and France will use a range of research methods to document how policy and program responses can be optimized the improve the lives of youth in both countries.

Dr. Michael Law, director of the Centre for Health Services and Policy Research and professor in the School of Population and Public Health, is receiving $341,941 from CIHR to co-lead a study aimed at reducing the impact of COVID-19 in resource-poor countries. Working with Partners In Health, the researchers will use health information systems to monitor for potential COVID-19 hotspots and monitor changes in health services use in Haiti, Lesotho, Liberia, Malawi, Mexico, Rwanda, and Sierra Leone. This data will be used to help inform national public health responses to mitigate the spread of COVID-19.

Dr. Teresa Liu-Ambrose, professor in the department of physical therapy at UBC and researcher at the Vancouver Coastal Health Research Institute, is receiving $722,703 from CIHR to investigate the possible impact of COVID-19 on cognition and the brain post-infection. To achieve this, she will be measuring both cognitive function and acquire brain scans from Canadians aged 55 to 80 years, enrolled in the Canadian Longitudinal Study on Aging. Researchers will compare the cognitive function, brain structure, and brain function of adults with suspected or confirmed COVID-19 with those who are symptom-free or who have tested negative.

A team led by Dr. Deborah Money, professor in the department of obstetrics and gynaecology, is receiving $825,367 from CIHR for CANCOVID-Preg, a surveillance study into maternal and infant outcomes among pregnant women with COVID-19. The nation-wide research will be conducted by teams working in provinces and territories across Canada, and will allow Canada to develop urgently needed, evidence-based recommendations for maternity and pediatric care providers, as well as pregnant women and their families. Researchers will also contribute data to international collaborations, allowing for more comprehensive global understanding of COVID-19 in pregnancy.

Dr. Alice Mui, associate professor in the departments of surgery and biochemistry and molecular biology and researcher at the Vancouver Coastal Health Research Institute, is receiving $150,072 from CIHR to investigate why some patients with COVID-19 experience a surge of inflammatory proteins, called a cytokine storm, that can contribute to the development of acute respiratory distress. Her team will investigate whether the SARS-Co-V2 virus blocks the function of an anti-inflammatory cytokine called interleukin-10 in the body. Her team will also assess whether a compound they have developed can mimic the action of this cytokine and reduce inflammation in patients infected with the COVID-19 virus.

A team led by Dr. Josef Penninger, professor in UBCs faculty of medicine, director of the Life Sciences Institute and the Canada 150 Research Chair in Functional Genetics at UBC, is receiving $578,090 from CIHR to support Phase 2 trials of a promising antiviral therapy. The trials will involve using doses of human recombinant soluble ACE2 (hrsACE2) as a decoy for the SARS-CoV-2 virus, which enters human cells by attaching to the ACE2 receptor protein. This treatment could also protect organs including lung, heart, blood vessels and kidney from injury due to high doses of antiviral therapies such as remdesivir and chloroquine.

Dr. James Russell, professor in the UBC department of medicine, is receiving $3.5 million from CIHR for a multi-site randomized controlled trial (RCT) to study the safety and effectiveness of using losartan, a drug commonly used to treat high blood pressure and diabetes, to lower COVID-19 mortality. Losartan is in a class of drug known as an ARBs, which have been shown to reduce viral load and lung injury in influenza pneumonia.

A team led by Dr. Amanda Slaunwhite, senior scientist with the BC Centre for Disease Control and an adjunct professor in the School of Population and Public Health, is receiving $777,439 from CIHR and $75,000 from the Michael Smith Foundation for Health Research. The researchers will assess the impact of the new risk-mitigation guidance that permits prescribing of pharmaceutical alternatives to the toxic drug supply. Researchers will determine the effects of the pandemic and risk mitigation measures on COVID-19 infection, continuity of care for treatment of substance use disorders and non-fatal and fatal overdose in BC. The researchers will also identify barriers and facilitators to implementation from the perspectives of people who use substances, prescribers, harm reduction workers, and other providers and community members.

The team is led by principal investigators at UBC, the Canadian Institute for Substance Use Research (CISUR) at the University of Victoria (Dr. Bernie Pauly and Dr. Karen Urbanoski) and Simon Fraser University (Dr. Bohdan Nosyk and Dr. Natt Hongdilokkul). The team includes co-investigators and collaborators from the First Nations Health Authority, Ministry of Mental Health and Addictions, BC Centre on Substance Use, the BCCDC-based Compassion Inclusion and Engagement (CIE) (PEEP) peer network, Provincial Health Services Authority, BC-Yukon Association of Drug War Survivors and Public Health Agency of Canada.

A team of Indigenous and allied researchers governed by the Cedar Project Partnership and led by Dr. Patricia Spittal, professor in the UBC School of Population and Public Health, is receiving $549,258 from CIHR for a year-long study into the impacts of COVID-19 among Indigenous people who use drugs. Researchers will also roll out and test a bundle of virtual supports using an existing technology platform to mitigate and manage the impacts of COVID-19 on this population. The study will run as part of the Cedar Project, which, since 2003, has examined connections between impacts of colonization and intergenerational trauma on HIV and hepatitis C virus among young Indigenous people who use drugs in Vancouver and Prince George. The Cedar Project is one of the only research studies that continued operating during the early stages of the COVID-19 outbreak, and will draw on its existing trust-based relationships with over 800 Indigenous people in both cities.

A team led by Dr. Natalie Strynadka, professor of biochemistry in the department of biochemistry and molecular biology, is receiving $403,065 from CIHR to lead research in the development of antiviral treatments for COVID-19 using molecular structure-based drug design. Working with professor Mark Paetzel at Simon Fraser University, professor David Baker at University of Washington and a long-time U.S. pharmaceutical partner, these researchers will assess and design drugs that inhibit processing enzymes active during viral reproduction, an approach that has been successfully used to develop antiviral treatments for HIV and other global viral infections.

Dr. Teresa Tsang, cardiologist, director of the VGH and UBC Echo Lab and professor of medicine at UBC, is receiving $260,326 from CIHR to lead a multi-centre study that will use ultrasound imaging and Big Data to enhance the accuracy of COVID-19 diagnosis and patient prognostication. Researchers will use point-of-care heart-lung ultrasound imaging in addition to nasal swab testing, and collaborate with UBC engineering professor Purang Abolmaesumi to develop AI methods that will enhance the sensitivity of COVID-19 detection.

A team led by Dr. Annalee Yassi, Canada Research Chair in Global Health and Capacity-Building in UBCs School of Population and Public Health, is receiving $410,256 from IDRC. Her team will work with collaborating organizations in Vancouver, B.C. and Guateng, South Africa to analyze what works to protect healthcare workers in Canada and South Africa from COVID-19. They will also draw on survey research on the protection of healthcare workers in other countries to help inform international policy and practice on protecting healthcare workers caring for patients with COVID-19.

A version of this story originally appeared on UBC News.

Go here to read the rest:

UBC faculty of medicine researchers receive nearly $14M in federal funding for COVID-19 research - UBC Faculty of Medicine

Impact of COVID-19 Outbreak on Medicine Automated Dispensing Cabinets Market to Witness BD, Omnicell, Takazono, TOSHO, Willach Group – Cole of Duty

Posted on June 26, 2020 by Danzig

Medicine Automated Dispensing Cabinets Market 2020

This report studies the Medicine Automated Dispensing Cabinets Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Medicine Automated Dispensing Cabinets Market analysis segmented by companies, region, type and applications in the report.

The major players covered in Medicine Automated Dispensing Cabinets Market BD, Omnicell, Takazono, TOSHO, Willach Group, YUYAMA, Aesynt, Cerner, Healthmark, KRZ, MTS Medication Technologies, S&S Technology, Beldico Integrated Solution, Swisslog, and TCGRx

The final report will add the analysis of the Impact of Covid-19 in this report Medicine Automated Dispensing Cabinets industry.

Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-medicine-automated-dispensing-cabinets-market-research-report-2018-one?utm_source=3wnews&utm_medium=36

Medicine Automated Dispensing Cabinets Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Medicine Automated Dispensing Cabinets Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Medicine Automated Dispensing Cabinets market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Medicine Automated Dispensing Cabinets market by identifying its various sub segments.

Focuses on the key global Medicine Automated Dispensing Cabinets players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Medicine Automated Dispensing Cabinets with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Medicine Automated Dispensing Cabinets submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The Medicine Automated Dispensing Cabinets Market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Table of Contents: Medicine Automated Dispensing Cabinets Market

Chapter 1: Overview of Medicine Automated Dispensing Cabinets Market

Chapter 2: Global Market Status and Forecast by Regions

Chapter 3: Global Market Status and Forecast by Types

Chapter 4: Global Market Status and Forecast by Downstream Industry

Chapter 5: Market Driving Factor Analysis

Chapter 6: Market Competition Status by Major Manufacturers

Chapter 7: Major Manufacturers Introduction and Market Data

Chapter 8: Upstream and Downstream Market Analysis

Chapter 9: Cost and Gross Margin Analysis

Chapter 10: Marketing Status Analysis

Chapter 11: Market Report Conclusion

Chapter 12: Research Methodology and Reference

Key questions answered in this report

What will the market size be in 2026 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Inquire More about This https://www.reportsandmarkets.com/enquiry/global-medicine-automated-dispensing-cabinets-market-research-report-2018-one?utm_source=3wnews&utm_medium=36

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Link:

Impact of COVID-19 Outbreak on Medicine Automated Dispensing Cabinets Market to Witness BD, Omnicell, Takazono, TOSHO, Willach Group - Cole of Duty

Select Page ::